Update shared on 22 Nov 2025
Fair value Decreased 3.57%CONMED's analyst price target has been reduced from $56 to $54 per share, as analysts cite modest cuts to growth and profit outlooks, along with slightly higher discount rates following recent sector updates.
Analyst Commentary
Analysts have provided a range of perspectives on CONMED’s outlook based on recent developments in company performance and sector trends. The updates reflect both confidence in certain business aspects and caution resulting from market headwinds and operational challenges.
Bullish Takeaways
- Bullish analysts highlight that ongoing margin initiatives are progressing, which helps to offset pressure from cost inflation.
- Resilience in municipal and non-residential segments continues to provide a foundation for revenue stability, even though residential markets remain soft.
- Overweight-rated analysts maintain a positive long-term view because of favorable trends in non-core business areas.
Bearish Takeaways
- Bearish analysts note that slower growth in the residential sector has prompted downward revisions to both guidance and price targets.
- Higher selling, general, and administrative expenses are seen as weighing on profit margins, and management’s full-year outlook reflects these pressures.
- Reduced growth expectations and slightly higher discount rates have resulted in more conservative valuations compared to previous outlooks.
What's in the News
- CONMED Corporation has announced a share repurchase program, authorizing the repurchase of up to $150 million in common stock (Key Developments).
- The company has completed the repurchase of over 6.1 million shares, representing 21.23% of shares, for $162.54 million under a buyback program announced previously (Key Developments).
- CONMED revised its 2025 full-year revenue guidance to a range of $1.365 billion to $1.372 billion, slightly narrowing previous estimates (Key Developments).
- The Board of Directors suspended the company's quarterly cash dividend as part of the decision to extend its share repurchase efforts (Key Developments).
- Recent tariff announcements are expected to negatively impact fourth quarter 2025 earnings per share by about $0.07 (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has declined from $56 to $54 per share. This reflects a modest reduction in perceived fair value.
- Discount Rate has risen slightly from 9.17% to 9.24%. This indicates updated sector risk assessments.
- Revenue Growth forecast remains essentially unchanged, moving fractionally from 5.33% to 5.33%.
- Net Profit Margin has decreased from 11.25% to 10.62%. This highlights slightly lower profitability expectations.
- Future P/E has increased from 12.75x to 13.05x. This implies the stock’s valuation multiple is now marginally higher based on revised earnings forecasts.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.